We are monitoring the impact of COVID-19 on Europe Ophthalmology Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Europe Ophthalmology Therapeutics Market Research Report – Segmented By Indication, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 1045
Pages: 145

Europe Ophthalmology Therapeutics Market Size (2022 to 2027)

The size of the Europe Ophthalmology Therapeutics Market was worth USD 6.88 billion in 2022. It is further estimated to be growing at a CAGR of 6.9% and value USD 9.61 billion by 2027.

The market is showing evident potential in the mentioned forecast period. Ophthalmology deals with the treatment of eye defects and diseases. Age-related macular degeneration is the major cause of visual loss in adults in industrialized countries; other conditions associated with vision loss include cataracts, diabetic retinopathy, and glaucoma, along with the low vision.

There are around 25 million people with visual impairment in Europe. It is estimated that more than 70 million people have eye diseases that are in the early stages which if left untreated may lead to severe impairment.

Europe Ophthalmology Therapeutics is driven by the increasing incidence of vision impairment. Advancements in technology in the field of medicine are also playing a key role in the growth of the market. The growing geriatric population across the continent along with an increase in disposable income of the people are some of the factors adding up to the market growth.

However, stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for market growth. Lack of awareness about various diseases associated with ophthalmology is also a major restraint hindering the market growth.

This research report on the European Ophthalmology Therapeutics Market has been segmented and sub-segmented the Market into the following categories:

By Indication: 

  • Glaucoma
  • Dry Eye Syndrome
  • Diabetic Retinopathy
  • Retinal Vein Occlusion
  • Age-related Macular Degeneration
  • Macular Edema
  • Allergic Conjunctivitis

By End User: 

  • Hospitals
  • Eye Clinics
  • Diagnostic Centres
  • Patients

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Within Europe, Germany is the largest market for Ophthalmology Therapeutics Glaucoma is the largest indication segment accounting for a share of approximately 31% followed by AMD with a share of XX%.

Companies playing a leading role in the European Ophthalmology Therapeutics Market are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Indication                              

                                5.1.1 Glaucoma

                                5.1.2 Dry Eye Syndrome

                                5.1.3 Diabetic Retinopathy         

                                5.1.4 Retinal Vein Occlusion        

                                5.1.5 Age-Related Macular Degeneration (AMD)

                                5.1.6 Macular Edema    

                                5.1.7 Allergic Conjunctivitis         

                5.2 By End User               

                                5.2.1 Hospitals  

                                5.2.2 Eye Clinics

                                5.2.3 Diagnostic Centers              

                                5.2.4 Patients   

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Allergan, Inc.                              

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck & Co Inc                         

                9.3 Pfizer                            

                9.4 Roche                           

                9.5 Novartis (Alcon)                       

                9.6 Valeant                        

                9.7 Regeneron                 

                9.8 Santen                         

                9.9 Bayer                            

                9.10 Senju                          

                9.11 Lpath                          

                9.12 Eye Gate Pharmaceuticals                 

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Ophthalmology Therapeutics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Europe Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  3. Europe Glaucoma Market, By Region, From 2022 - 2027 (USD Billion)
  4. Europe Dry Eye Syndrome Market, By Region, From 2022 - 2027 (USD Billion)
  5. Europe Diabetic Retinopathy Market, By Region, From 2022 - 2027 (USD Billion)
  6. Europe Retinal Vein Occlusion Market, By Region, From 2022 - 2027 (USD Billion)
  7. Europe Age-Related Macular Degeneration (AMD) Market, By Region, From 2022 - 2027 (USD Billion)
  8. Europe Macular Edema Market, By Region, From 2022 - 2027 (USD Billion)
  9. Europe Allergic Conjunctivitis Market, By Region, From 2022 - 2027 (USD Billion)
  10. Europe Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  11. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  12. Europe Eye Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Europe Diagnostic Centers Market, By Region, From 2022 - 2027 (USD Billion)
  14. Europe Patients Market, By Region, From 2022 - 2027 (USD Billion)
  15. U.K Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  16. U.K Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  17. Spain Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  18. Spain Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  19. Germany Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  20. Germany Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  21. Italy Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  22. Italy Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)
  23. France Ophthalmology Therapeutics Market, By Indication, From 2022 - 2027 (USD Billion)
  24. France Ophthalmology Therapeutics Market, By End-User, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample